Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?

Anesthesiology. 2010 Jan;112(1):16-8. doi: 10.1097/ALN.0b013e3181c5388f.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acetylcholine / metabolism
  • Acetylcholinesterase / pharmacology
  • Anesthesia Recovery Period
  • Animals
  • Cholinesterase Inhibitors / administration & dosage*
  • Cholinesterase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Humans
  • Monitoring, Intraoperative
  • Neostigmine / administration & dosage*
  • Neostigmine / pharmacology*
  • Neuromuscular Junction / drug effects
  • Neuromuscular Junction / metabolism
  • Neuromuscular Nondepolarizing Agents / antagonists & inhibitors*
  • Recovery of Function

Substances

  • Cholinesterase Inhibitors
  • Neuromuscular Nondepolarizing Agents
  • Neostigmine
  • Acetylcholinesterase
  • Acetylcholine